European Lung Cancer Congress 2024

Abstracts and ePosters: Open Access
Slides and Webcasts: Available to ESMO Members and registered delegates, subject to presenters' consent

The copyright protected educational resources from this event are for personal usage only and not to be shared with any third parties. ESMO thanks the authors for their generosity.

Review the current state-of-the-art in lung cancer therapy, update your knowledge in prevention, screening, detection and much more.

The European Lung Cancer Congress 2024 provides insights into the prevention, diagnosis, biology and multi-disciplinary management of thoracic malignancies. Learning objectives included updating knowledge in early detection, reviewing current state-of-the-art systemic management, the emerging contribution of precision medicine, genomics technologies and artificial intelligence.

ESMO Colloquium supported by Eli Lilly & Company
Optimising molecular diagnosis and precision therapy in patients with advanced NSCLC harbouring rare oncogenic translocations

Slides and Webcasts

Industry partners' Satellite Symposia

Watch the webcasts